DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

MS Contin (Morphine) - Renal Failure Acute - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Renal Failure Acute (12)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to MS Contin (Morphine) where reactions include renal failure acute. The selected reports were submitted to the FDA during the sample period of about a year.

Possible MS Contin side effects in male

Reported by a physician from United States on 2012-08-23

Patient: male, weighing 140.6 kg (309.3 pounds)

Reactions: Myoclonus, Renal Failure Acute

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
MS Contin
    Dosage: 30 mg, tid
    Administration route: Oral
    Indication: Pain

Oxycodone HCL
    Dosage: 40 mg, bid
    Administration route: Oral
    Indication: Pain
    Start date: 2012-08-02
    End date: 2012-08-09

Other drugs received by patient: Fish OIL; Stool Softener; Potassium; Dulcolax; Amitriptyline Hydrochloride; Omeprazole; Morphine Sulfate; Lasix; Metformin; Neurontin; Simvastatin; Lisinopril; Coumadin; Fenofibrate



Possible MS Contin side effects in 54 year old female

Reported by a physician from United States on 2012-08-13

Patient: 54 year old female, weighing 55.8 kg (122.7 pounds)

Reactions: Vomiting, Nausea, Diarrhoea, Dehydration, Renal Failure Acute

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Aleve
    Administration route: Oral
    Indication: Pain
    Start date: 2012-06-12
    End date: 2012-06-13

Doxycycline HCL
    Administration route: Oral
    Indication: non-Small Cell Lung Cancer
    Start date: 2012-05-29
    End date: 2012-06-20

Motrin
    Administration route: Oral
    Indication: Pain
    Start date: 2011-12-19
    End date: 2012-06-11

MS Contin
    Administration route: Oral
    Indication: Pain
    Start date: 2012-06-12
    End date: 2012-06-12

Unknown Medication
    Administration route: Oral
    Indication: non-Small Cell Lung Cancer
    Start date: 2012-05-29
    End date: 2012-06-18

Zofran
    Indication: Nausea
    Start date: 2012-06-17
    End date: 2012-06-19

Other drugs received by patient: Vitamin B-12; Ascorbic Acid; Pamidronate Disodium; Vitamine E; Multiple Vitamin; Folic Acid; Vitamin D



Possible MS Contin side effects in 81 year old female

Reported by a health professional (non-physician/pharmacist) from Italy on 2012-08-13

Patient: 81 year old female

Reactions: Renal Failure Acute, Lethargy

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
MS Contin
    Dosage: unk
    Indication: Pain
    Start date: 2012-06-27
    End date: 2012-06-30

Oramorph SR
    Dosage: 12 drop, daily
    Administration route: Oral
    Start date: 2012-06-27
    End date: 2012-06-30

Other drugs received by patient: Gabapentin; Bisoprolol; Clonazepam; Omeprazole; Femara



Possible MS Contin side effects in 54 year old female

Reported by a physician from United States on 2012-08-08

Patient: 54 year old female, weighing 55.8 kg (122.7 pounds)

Reactions: Diarrhoea, Nausea, Dehydration, Renal Failure Acute

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Dacomitinib
    Dosage: 45 mg, cohorts i and ii daily continous
    Start date: 2012-06-26

Dacomitinib
    Dosage: 45 mg, cohorts i and ii daily continous
    Indication: non-Small Cell Lung Cancer
    Start date: 2012-05-29
    End date: 2012-06-18

Doxycycline HCL
    Dosage: 100 mg, bid
    Administration route: Oral
    Indication: non-Small Cell Lung Cancer
    Start date: 2012-05-29
    End date: 2012-06-20

MS Contin
    Dosage: 15 mg, bid
    Administration route: Oral
    Indication: Pain
    Start date: 2012-06-12
    End date: 2012-06-12

Naproxen (Aleve)
    Dosage: 220 mg, bid
    Administration route: Oral
    Indication: Pain
    Start date: 2012-06-12
    End date: 2012-06-13

Other drugs received by patient: Folic Acid; Vitamin E; Ascorbic Acid; Vitamin B-12; Vitamin D; Pamidronate Disodium; Theragran-M; Motrin



Possible MS Contin side effects in 81 year old female

Reported by a health professional (non-physician/pharmacist) from Italy on 2012-08-03

Patient: 81 year old female

Reactions: Respiratory Depression, Lethargy, Renal Failure Acute

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
MS Contin
    Dosage: 20 mg, daily
    Administration route: Oral
    Indication: Pain
    Start date: 2011-01-01
    End date: 2012-06-19

Oramorph SR
    Dosage: 12 gtt, daily
    Administration route: Oral
    Indication: Pain
    Start date: 2012-01-01
    End date: 2012-06-19

Other drugs received by patient: Femara; Omeprazole; Bisoprolol Hemifumarate / Hydrochlorothiazide; Ferrofolin; Gabapentin; Rivotril



Possible MS Contin side effects in 81 year old female

Reported by a health professional (non-physician/pharmacist) from Italy on 2012-07-31

Patient: 81 year old female

Reactions: Respiratory Depression, Renal Failure Acute, Lethargy

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
MS Contin
    Dosage: 20 mg, daily
    Administration route: Oral
    Start date: 2012-07-27

MS Contin
    Dosage: 20 mg, daily
    Administration route: Oral
    Indication: Pain
    Start date: 2011-01-01
    End date: 2012-06-19

Oramorph SR
    Dosage: 12 gtt, daily
    Administration route: Oral
    Start date: 2012-07-27

Oramorph SR
    Dosage: 12 gtt, daily
    Administration route: Oral
    Indication: Pain
    Start date: 2012-01-01
    End date: 2012-06-19

Other drugs received by patient: Gabapentin; Omeprazole; Bisoprolol Hemifumarate / Hydrochlorothiazide; Ferrofolin; Rivotril; Femara



Possible MS Contin side effects in female

Reported by a health professional (non-physician/pharmacist) from Italy on 2012-07-26

Patient: female

Reactions: Respiratory Depression, Renal Failure Acute, Lethargy

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
MS Contin
    Dosage: 20 mg, daily
    Administration route: Oral
    Indication: Pain
    Start date: 2011-01-01
    End date: 2012-06-19

Oramorph SR
    Dosage: 12 drop, daily
    Administration route: Oral
    Indication: Pain
    Start date: 2012-01-01
    End date: 2012-06-19

Other drugs received by patient: Bisoprolol Fumarate; Gabapentin; Omeprazole; Femara; Ferrofolin; Clonazepam



Possible MS Contin side effects in 54 year old female

Reported by a physician from United States on 2012-07-17

Patient: 54 year old female, weighing 55.8 kg (122.7 pounds)

Reactions: Vomiting, Diarrhoea, Nausea, Dehydration, Blood Creatine Increased, Renal Failure Acute

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Aleve
    Dosage: 220 mg, bid
    Administration route: Oral
    Indication: Pain
    Start date: 2012-06-12
    End date: 2012-06-13

Doxycycline
    Dosage: 100 mg, bid
    Administration route: Oral
    Indication: non-Small Cell Lung Cancer
    Start date: 2012-05-29
    End date: 2012-06-20

Motrin
    Dosage: 800 mg, bid
    Administration route: Oral
    Indication: Pain
    Start date: 2011-12-19
    End date: 2012-06-12

MS Contin
    Dosage: 15 mg, bid
    Administration route: Oral
    Indication: Pain
    Start date: 2012-06-12
    End date: 2012-06-12

Study Drug
    Dosage: 45 mg, unk
    Indication: non-Small Cell Lung Cancer
    Start date: 2012-05-29
    End date: 2012-06-18

Zofran
    Dosage: 4 mg, q6h
    Indication: Nausea
    Start date: 2012-06-17
    End date: 2012-06-19

Other drugs received by patient: Theragran-M / 00610701 /; Vitamin D; Folic Acid; B12 / 00056201 /; Vitamin C / 00008001 /; Pamidronate Disodium; Vitamin E / 00110501 /



Possible MS Contin side effects in 54 year old female

Reported by a physician from United States on 2012-07-13

Patient: 54 year old female, weighing 55.8 kg (122.7 pounds)

Reactions: Vomiting, Diarrhoea, Nausea, Dehydration, Blood Creatine Increased, Renal Failure Acute

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Aleve
    Dosage: 220 mg, bid
    Administration route: Oral
    Indication: Pain
    Start date: 2012-06-12
    End date: 2012-06-13

Doxycycline
    Dosage: 100 mg, bid
    Administration route: Oral
    Indication: non-Small Cell Lung Cancer
    Start date: 2012-05-29
    End date: 2012-06-20

Motrin
    Dosage: 800 mg, bid
    Administration route: Oral
    Indication: Pain
    Start date: 2011-12-19
    End date: 2012-06-12

MS Contin
    Dosage: 15 mg, bid
    Administration route: Oral
    Indication: Pain
    Start date: 2012-06-12
    End date: 2012-06-12

Study Drug
    Dosage: 45 mg, unk
    Indication: non-Small Cell Lung Cancer
    Start date: 2012-05-29
    End date: 2012-06-18

Zofran
    Dosage: 4 mg, q6h
    Indication: Nausea
    Start date: 2012-06-17
    End date: 2012-06-19

Other drugs received by patient: Vitamin D; Theragran-M / 00610701 /; B12 / 00056201 /; Vitamin C / 00008001 /; Vitamin E / 00110501 /; Pamidronate Disodium; Folic Acid



Possible MS Contin side effects in 54 year old female

Reported by a physician from United States on 2012-07-06

Patient: 54 year old female, weighing 55.8 kg (122.7 pounds)

Reactions: Vomiting, Nausea, Diarrhoea, Dehydration, Blood Creatine Increased, Renal Failure Acute

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Aleve
    Dosage: 220 mg, bid
    Administration route: Oral
    Indication: Pain
    Start date: 2012-06-12
    End date: 2012-06-13

Doxycycline Hyclate
    Dosage: 100 mg, bid
    Administration route: Oral
    Indication: non-Small Cell Lung Cancer
    Start date: 2012-05-29
    End date: 2012-06-20

Motrin
    Dosage: 800 mg, bid
    Administration route: Oral
    Indication: Pain
    Start date: 2011-12-19
    End date: 2012-06-12

MS Contin
    Dosage: 15 mg, bid
    Administration route: Oral
    Indication: Pain
    Start date: 2012-06-12
    End date: 2012-06-12

Study Drug
    Dosage: 45 mg, unk
    Indication: non-Small Cell Lung Cancer
    Start date: 2012-05-29
    End date: 2012-06-18

Zofran
    Dosage: 4 mg, q6h
    Indication: Nausea
    Start date: 2012-06-17
    End date: 2012-06-19

Other drugs received by patient: Pamidronate Disodium; Folic Acid; Theragran-M / 00610701 /; B12 / 00056201 /; Vitamin E / 00110501 /; Vitamin C / 00008001 /; Vitamin D



Possible MS Contin side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-02

Patient: female

Reactions: Pulmonary Hypertension, Biliary Tract Operation, Drug Ineffective, Pancreatic Neoplasm, Death, Hepatic Encephalopathy, Oesophagitis, Cholangitis, Pancreatitis Chronic, Gastrooesophageal Reflux Disease, Renal Failure Acute, Dysphagia, Metabolic Acidosis, Type 2 Diabetes Mellitus, Hypotension, Renal Failure Chronic, Cerebrovascular Accident, Hyperlipidaemia, Diarrhoea, Liver Transplant Rejection, Feeling Abnormal, Hypertension, Herpes Virus Infection

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Lactulose
    Dosage: unk
    Indication: Product Used FOR Unknown Indication

MS Contin
    Dosage: unk
    Indication: Pain

Prograf
    Dosage: 0.5 unk, q3d
    Start date: 2012-01-01
    End date: 2012-01-29

Prograf
    Dosage: 0.5 mg, bid
    Administration route: Oral
    Indication: Liver Transplant
    Start date: 1997-07-08
    End date: 2012-01-01

Other drugs received by patient: Diflucan; Sodium Bicarbonate; Carafate; Morphine; Oxycodone HCL; Xifaxan; MAG-OX; Protonix; Insulin; Creon; Metoprolol Succinate



Possible MS Contin side effects in female

Reported by a consumer/non-health professional from United States on 2012-03-19

Patient: female

Reactions: Pulmonary Hypertension, Biliary Tract Operation, Drug Ineffective, Pancreatic Neoplasm, Death, Hepatic Encephalopathy, Oesophagitis, Cholangitis, Pancreatitis Chronic, Gastrooesophageal Reflux Disease, Renal Failure Acute, Type 2 Diabetes Mellitus, Dysphagia, Metabolic Acidosis, Hypotension, Renal Failure Chronic, Cerebrovascular Accident, Hyperlipidaemia, Diarrhoea, Liver Transplant Rejection, Hypertension, Feeling Abnormal, Herpes Virus Infection

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Lactulose
    Dosage: unk
    Indication: Product Used FOR Unknown Indication

MS Contin
    Dosage: unk
    Indication: Pain

Prograf
    Dosage: 0.5 unk, q3d
    Start date: 2012-01-01
    End date: 2012-01-29

Prograf
    Dosage: 0.5 mg, bid
    Administration route: Oral
    Indication: Liver Transplant
    Start date: 1997-07-08
    End date: 2012-01-01

Other drugs received by patient: Morphine; Oxycodone HCL; Metoprolol Succinate; Creon; Xifaxan; Protonix; Sodium Bicarbonate; Insulin; MAG-OX; Diflucan; Carafate

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017